Zoetis Faces Wall Street Today at Stifel Conference Following Q1 Market Shock

NEW YORK, NY — In what is widely regarded as the most critical and closely watched corporate event on the 2026 animal health investors’ calendar, Zoetis Inc. (NYSE: ZTS) management is scheduled to participate in a live fireside chat at the Stifel Jaws & Paws Conference today, Thursday, May 28, at 3:00 PM Eastern Time.

This presentation represents a high-stakes moment for the global animal health leader, Zoetis. This is the first time executive leadership will face buy-side analysts and institutional investors in a live forum since the company’s Q1 earnings release on May 7, which triggered a sharp 25% decline in its stock price due to missing key quarterly growth projections.

Contextualizing Stakes: Post-May 7 Recovery Play

Zoetis presentation today comes at a critical time for Zoetis. While the animal health giant has historically maintained a premium valuation due to its dominant companion animal pipelines—led by blockbuster franchises like Apoquel®, Cytopoint®, and Librela®—the Q1 earnings miss introduced reality check to the stockholders.

Buy-side investors are looking for specific strategic clarity on several key fronts:

• Companion Animal Traction: Updates on the market adoption of its long-acting canine osteoarthritis and monoclonal antibody therapies amid rising competition in its key markets

• Supply Chain and Margin Pressures: Clarification on manufacturing capacities and input costs that impacted the Q1 margins

• Genomics Integration: Progress on integrating Neogen’s global genomics assets to drive high-margin precision livestock workflows

A live, listen-only audio webcast of the fireside chat will be broadcasted through the company’s investor relations portal at investor.zoetis.com, with an archived replay made available later today.

Defensive Action: Board Declares Q3 2026 Dividend

Signaling underlying balance sheet strength and a commitment to shareholder returns despite recent equity headwinds, Zoetis separately announced that its Board of Directors has formally declared a third-quarter cash dividend.

• Dividend Payout: $0.53 per share on the company’s common stock

• Key Calendar Dates: The dividend is officially payable on September 1, 2026, to all shareholders of record at the close of business on July 20, 2026

The dividend declaration serves as an important signal to the market ahead of the Stifel presentation, emphasizing that Zoetis’s cash flow generation remains structurally sound enough to sustain capital allocation priorities and support its long-term dividend growth track.

What to Watch at 3:00 PM ET

Wall Street will be listening closely to how management addresses the recent drop in stock price. Analysts expect the discussion to move past the temporary Q1 setbacks and focus heavily on Zoetis’s long-term competitive advantages. Key areas of interest include the company’s multi-year pipeline defenses, international commercial expansion, and its ability to maintain pricing power in a shifting macroeconomic climate.